Ledger.Open graph →
SEC Form D · filed April 15, 2014

Adaptive Biotechnologies Corp

Offering
$105.0M
Sold
$105.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Paul A. Mahon · Winnipeg, Manitoba, CanadaDirectorJoshua D. Rand · New York, NYExec · DirectorChris Carlson · SEATTLE, WAExecC.A. Hennies · Atlanta, GADirectorJustin Mahoney · Stamford, CTDirectorJeffery Wright · Atlanta, GADirectorHarlan Robins · SEATTLE, WAExecPatrick Kullman · Atlanta, GADirectorSamer Atiani · Rego Park, NYDirectorJames Andrews · Atlanta, GAExec · DirectorJarrett Gorlin · Atlanta, GADirectorJohn Thomas, Jr · Atlanta, GADirectorLarry Papasan · Atlanta, GADirectorGregory D. Tretiak · Winnipeg, Manitoba, CanadaDirectorAndrew D. Brands · Winnipeg, Manitoba, CanadaDirectorJoshua Funder · San Diego, CAExecJohan Kordel · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗